Dr. Rogerio Vivaldi the President of Genzyme Corporation on the Transformation of Gaucher Disease
Rogerio Vivaldi, MD
Advertisement
Articles by Rogerio Vivaldi, MD
Advertisement
Latest Updated Articles
Dr. Vivaldi on the Gaucher Disease TransformationPublished: October 24th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5